KPMA, NHIC raise battle for insurance drugs' price comparison

Published: 2007-01-31 06:57:00

Updated: 2007-01-31 06:57:00

The Korea Pharmaceutical Manufacturers Association (KPMA) and the National Health Insurance Corporation (NHIC) are clashing head-on over the KPMA's report that Korea's top 500-drug prices covered by the national health insurance is in the level of 57.1 percent compared with those of seven advance...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK